Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates

A. J. L. M. Geraerds*, Wendy Van Herk, Martin Stocker, Salhab El Helou, Sourabh Dutta, Matteo S. Fontana, Frank A. B. A. Schuerman, Rita K. Van Den Tooren-de Groot, Jantien Wieringa, Jan Janota, Laura H. Van Der Meer-kappelle, Rob Moonen, Sintha D. Sie, Esther De Vries, Albertine E. Donker, Urs Zimmerman, Luregn J. Schlapbach, Amerik C. De Mol, Angelique Hoffman-haringsma, Madan RoyMaren Tomaske, René F. Kornelisse, Juliette Van Gijsel, Eline G. Visser, Annemarie M. C. Van Rossum, Suzanne Polinder

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

57 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science